» Articles » PMID: 35315229

Deep Learning-Assisted Automated Single Cell Electroporation Platform for Effective Genetic Manipulation of Hard-to-Transfect Cells

Overview
Journal Small
Date 2022 Mar 22
PMID 35315229
Authors
Affiliations
Soon will be listed here.
Abstract

Genome engineering of cells using CRISPR/Cas systems has opened new avenues for pharmacological screening and investigating the molecular mechanisms of disease. A critical step in many such studies is the intracellular delivery of the gene editing machinery and the subsequent manipulation of cells. However, these workflows often involve processes such as bulk electroporation for intracellular delivery and fluorescence activated cell sorting for cell isolation that can be harsh to sensitive cell types such as human-induced pluripotent stem cells (hiPSCs). This often leads to poor viability and low overall efficacy, requiring the use of large starting samples. In this work, a fully automated version of the nanofountain probe electroporation (NFP-E) system, a nanopipette-based single-cell electroporation method is presented that provides superior cell viability and efficiency compared to traditional methods. The automated system utilizes a deep convolutional network to identify cell locations and a cell-nanopipette contact algorithm to position the nanopipette over each cell for the application of electroporation pulses. The automated NFP-E is combined with microconfinement arrays for cell isolation to demonstrate a workflow that can be used for CRISPR/Cas9 gene editing and cell tracking with potential applications in screening studies and isogenic cell line generation.

Citing Articles

Mechanically mediated cargo delivery to cells using microfluidic devices.

Mao Z, Shi B, Wu J, Gao X Biomicrofluidics. 2024; 18(6):061302.

PMID: 39649102 PMC: 11624913. DOI: 10.1063/5.0240667.


Well Plate-Based Localized Electroporation Workflow for Rapid Optimization of Intracellular Delivery.

Patino C, Sarikaya S, Mukherjee P, Pathak N, Espinosa H Bio Protoc. 2024; 14(14):e5037.

PMID: 39100599 PMC: 11291937. DOI: 10.21769/BioProtoc.5037.


The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: A systematic scoping review.

Vo Q, Saito Y, Ida T, Nakamura K, Yuasa S PLoS One. 2024; 19(5):e0302537.

PMID: 38771829 PMC: 11108174. DOI: 10.1371/journal.pone.0302537.


Single-cell nanobiopsy enables multigenerational longitudinal transcriptomics of cancer cells.

Marcuccio F, Chau C, Tanner G, Elpidorou M, Finetti M, Ajaib S Sci Adv. 2024; 10(10):eadl0515.

PMID: 38446884 PMC: 10917339. DOI: 10.1126/sciadv.adl0515.


Tissue Nanotransfection Silicon Chip and Related Electroporation-Based Technologies for In Vivo Tissue Reprogramming.

Xuan Y, Wang C, Ghatak S, Sen C Nanomaterials (Basel). 2024; 14(2).

PMID: 38276735 PMC: 10820803. DOI: 10.3390/nano14020217.


References
1.
Chen Y, Wang J, Li X, Hu N, Voelcker N, Xie X . Emerging Roles of 1D Vertical Nanostructures in Orchestrating Immune Cell Functions. Adv Mater. 2020; 32(40):e2001668. PMC: 7461044. DOI: 10.1002/adma.202001668. View

2.
Datlinger P, Rendeiro A, Schmidl C, Krausgruber T, Traxler P, Klughammer J . Pooled CRISPR screening with single-cell transcriptome readout. Nat Methods. 2017; 14(3):297-301. PMC: 5334791. DOI: 10.1038/nmeth.4177. View

3.
Kang W, McNaughton R, Espinosa H . Micro- and Nanoscale Technologies for Delivery into Adherent Cells. Trends Biotechnol. 2016; 34(8):665-678. PMC: 4958582. DOI: 10.1016/j.tibtech.2016.05.003. View

4.
Shi Y, Inoue H, Wu J, Yamanaka S . Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2016; 16(2):115-130. PMC: 6416143. DOI: 10.1038/nrd.2016.245. View

5.
Steyer B, Bu Q, Cory E, Jiang K, Duong S, Sinha D . Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection. Stem Cell Reports. 2018; 10(2):642-654. PMC: 5830934. DOI: 10.1016/j.stemcr.2017.12.004. View